Sionna Therapeutics, Inc. (NASDAQ: SION), a burgeoning name in the biotechnology sector, is capturing investor attention with a significant potential upside of 42.10%. Specializing in the development of treatments for..
Niagen Bioscience, Inc. (NASDAQ: NAGE) is emerging as a noteworthy player in the biotechnology sector, specifically within the healthcare industry. With its focus on developing innovative healthy aging products, Niagen..
Tilray Brands, Inc. (NASDAQ: TLRY) stands out in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. This Canadian-based company has been navigating the evolving landscape of..
For investors scanning the volatile biotech sector, GH Research PLC (NASDAQ: GHRS) offers a compelling proposition. This Dublin-based clinical-stage biopharmaceutical company, currently valued at $940.99 million, is making significant strides..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is drawing significant attention from investors, thanks to its impressive potential upside and robust pipeline in the biotechnology sector. With a market capitalization of $1.9..
For investors with an eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) presents a compelling opportunity, particularly given its potential upside of 46.14% based on analyst target prices. This..
Sonida Senior Living, Inc. (SNDA) stands as a notable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $680.59 million, the company..
OrthoPediatrics Corp. (NASDAQ: KIDS), a leader in pediatric orthopedic solutions, is capturing investor attention with its innovative product lineup and a compelling market position in the healthcare sector. Specializing in..
Precigen, Inc. (NASDAQ: PGEN), a cutting-edge biopharmaceutical company, has garnered significant attention from investors due to its promising prospects in the biotechnology sector. With a current market capitalization of $1.19..
Upstream Bio, Inc. (UPB), a promising player in the biotechnology sector, is garnering attention with its notable potential for substantial stock appreciation. As a clinical-stage biotechnology company based in Waltham,..
Tyra Biosciences, Inc. (NASDAQ: TYRA) has captured the attention of investors with its promising pipeline and significant upside potential. As a clinical-stage biotechnology company, Tyra is at the forefront of..
Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, particularly in the diagnostics and research industry. Headquartered in Friendswood, Texas, this molecular diagnostics company has carved out..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, stands at the forefront of developing innovative cell and exosome-based therapeutics. With its focus on addressing unmet medical needs, particularly in..
Verastem, Inc. (NASDAQ: VSTM), a biotechnology company based in Needham, Massachusetts, has caught the eye of investors with its ambitious ventures in the healthcare sector. Specializing in the development of..
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a dynamic player in the biotechnology sector, has been capturing attention with its promising pipeline and significant upside potential. With a current market capitalization..
For investors with a keen eye on the healthcare sector, Semler Scientific, Inc. (NASDAQ: SMLR) presents a compelling opportunity. Operating within the medical devices industry, Semler Scientific is making strides..
Investors exploring opportunities within the healthcare sector might find RxSight, Inc. (RXST) an intriguing candidate, especially given its potential upside of over 30% as indicated by recent analyst ratings. Despite..
Investors with an eye on the healthcare sector might find Cullinan Therapeutics, Inc. (NASDAQ: CGEM) a compelling opportunity, especially given its promising potential for nearly 96% upside. The biopharmaceutical company,..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a burgeoning player in the biotechnology sector, is poised to capture investor attention with its staggering potential upside of 156.47%. Specializing in the development of..
Personalis, Inc. (NASDAQ: PSNL), a notable player in the healthcare sector, specifically in the diagnostics and research industry, is capturing investor attention with its innovative approach to cancer genomics. With..
